| Nome |
# |
|
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry, file e2913fdf-4f44-f688-e053-3705fe0a67e0
|
326
|
|
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle, file e2913fdf-8ba6-f688-e053-3705fe0a67e0
|
271
|
|
Dilated Cardiomyopathy. From Genetics to Clinical Management, file e2913fdd-2423-f688-e053-3705fe0a67e0
|
265
|
|
Role of Titin Missense Variants in Dilated Cardiomyopathy, file e2913fda-06bf-f688-e053-3705fe0a67e0
|
243
|
|
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies, file ada7573b-88e5-40dd-9c1c-f795b21c97cd
|
234
|
|
Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives, file e2913fdc-6ac9-f688-e053-3705fe0a67e0
|
224
|
|
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry, file e2913fde-f4e7-f688-e053-3705fe0a67e0
|
201
|
|
Restrictive cardiomyopathy: definition and diagnosis, file a1ded043-40c4-47b3-80cc-0dee95734dcd
|
185
|
|
Myocarditis in Clinical Practice, file e2913fdf-501f-f688-e053-3705fe0a67e0
|
185
|
|
Natural History of Dilated Cardiomyopathy in Children, file e2913fda-8192-f688-e053-3705fe0a67e0
|
177
|
|
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History, file e2913fdd-3de0-f688-e053-3705fe0a67e0
|
172
|
|
Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias, file e2913fda-9b7d-f688-e053-3705fe0a67e0
|
171
|
|
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures, file e2913fdc-c669-f688-e053-3705fe0a67e0
|
162
|
|
Chapter 6: Clinical Presentation, Spectrum of Disease, and Natural History, file e2913fdd-1dc4-f688-e053-3705fe0a67e0
|
145
|
|
Historical Terminology, Classifications, and Present Definition of DCM., file e2913fdc-ddd2-f688-e053-3705fe0a67e0
|
143
|
|
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study, file 275f565e-7f11-45d2-b2fb-df1c10eb9581
|
129
|
|
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry, file 3e7eefc1-5132-42c2-9726-179ab7427e0a
|
127
|
|
Myocarditis evolving in cardiomyopathy: When genetics and offending causes work together, file e2913fdd-1899-f688-e053-3705fe0a67e0
|
126
|
|
Detection of subjects with ischemic heart disease by using machine learning technique based on heart rate total variability parameters, file e2913fdd-f60b-f688-e053-3705fe0a67e0
|
122
|
|
The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy, file e2913fdd-786e-f688-e053-3705fe0a67e0
|
116
|
|
Chapter 12: Prognostic Stratification and Importance of Follow-Up, file e2913fdc-eb75-f688-e053-3705fe0a67e0
|
111
|
|
Chapter 14: Unresolved Issues and Future Perspectives, file e2913fdd-2496-f688-e053-3705fe0a67e0
|
111
|
|
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy, file e2913fdf-8687-f688-e053-3705fe0a67e0
|
109
|
|
Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors, file e2913fdc-e2e5-f688-e053-3705fe0a67e0
|
108
|
|
Chapter 3: Pathophysiology, file e2913fdd-03b2-f688-e053-3705fe0a67e0
|
106
|
|
Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences, file e2913fdd-55a0-f688-e053-3705fe0a67e0
|
105
|
|
Sex-Specific Prognostic Implications in Dilated Cardiomyopathy After Left Ventricular Reverse Remodeling, file e2913fde-0f8b-f688-e053-3705fe0a67e0
|
104
|
|
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach, file e2913fdd-2495-f688-e053-3705fe0a67e0
|
102
|
|
Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy, file 468c9389-c517-4b5d-aeca-999914bd5b8c
|
94
|
|
Pragmatic electrocardiogram tracings in non-ischaemic dilated cardiomyopathy: diagnostic and prognostic role, file 92ce5db7-d505-4631-8065-15f626ef5be1
|
94
|
|
Cardiac Magnetic Resonance in Primary Prevention of Sudden Cardiac Death, file e2913fdd-559e-f688-e053-3705fe0a67e0
|
94
|
|
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy, file e2913fdd-52a2-f688-e053-3705fe0a67e0
|
93
|
|
Contemporary etiology and prognosis of dilated non-ischemic cardiomyopathy, file a4a4b25b-8c22-4c1b-8154-e162ac59a90b
|
92
|
|
Standardizing the role of endomyocardial biopsy in current clinical practice worldwide, file 4b2c8317-9121-4273-8471-2c9e07d876fa
|
90
|
|
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world, file e2913fdd-8efd-f688-e053-3705fe0a67e0
|
87
|
|
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies, file e2913fde-c682-f688-e053-3705fe0a67e0
|
85
|
|
Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients, file e2913fdf-a324-f688-e053-3705fe0a67e0
|
85
|
|
Myocarditis: Which Role for Genetics?, file e2913fde-b7f6-f688-e053-3705fe0a67e0
|
84
|
|
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy, file e2913fde-bd7a-f688-e053-3705fe0a67e0
|
81
|
|
Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist?, file e2913fda-a49e-f688-e053-3705fe0a67e0
|
80
|
|
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy, file b94d515a-becd-4903-a261-cc573898540d
|
78
|
|
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy, file e2913fdd-c34a-f688-e053-3705fe0a67e0
|
77
|
|
The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM, file e2913fdf-16c7-f688-e053-3705fe0a67e0
|
77
|
|
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value, file a888026b-a89e-476f-bc87-4fd775b36001
|
71
|
|
Endomyocardial biopsy in the clinical context: current indications and challenging scenarios, file cffba854-da3e-4622-85c6-31f22fc853a6
|
68
|
|
Aspirin and Infection: A Narrative Review, file e2913fdf-2066-f688-e053-3705fe0a67e0
|
66
|
|
Acute inflammatory cardiomyopathy: apparent neutral prognostic impact of immunosuppressive therapy, file e2913fdf-6113-f688-e053-3705fe0a67e0
|
66
|
|
Clinical characterization and natural history of chemotherapy-induced dilated cardiomyopathy, file 1255335d-504a-4954-b06e-92e335f68952
|
64
|
|
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies, file b0e9a5c9-c8eb-4279-af3f-4c444ec2a703
|
62
|
|
Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors, file e2913fde-d56b-f688-e053-3705fe0a67e0
|
62
|
|
Echocardiographic evaluation of centenarians in Trieste, file e2913fdf-7633-f688-e053-3705fe0a67e0
|
62
|
|
Lymphocytic Myocarditis: A Genetically Predisposed Disease?, file e2913fdf-62b6-f688-e053-3705fe0a67e0
|
59
|
|
Cardiac amyloidosis: a changing epidemiology with open challenges, file 160fae5f-8cf4-4fe8-81d7-23ae8ca9512f
|
58
|
|
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology, file 9f414efc-929b-411c-86c4-2bba392c0a69
|
52
|
|
Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study, file e2913fdd-9c70-f688-e053-3705fe0a67e0
|
52
|
|
Best of European Journal of Heart Failure at the ESC/HFA Heart Failure Congress 2021, file 5adef6c8-799c-4efe-b307-e6155c48f159
|
50
|
|
Conflicting gender-related differences in the natural history of patients with idiopathic dilated cardiomyopathy, file e2913fdb-c958-f688-e053-3705fe0a67e0
|
50
|
|
The impossible interviews-Sherlock Holmes interviews David Sackett: 'how much can we trust the guidelines?', file e2913fde-885a-f688-e053-3705fe0a67e0
|
47
|
|
Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome registry, file e2913fdf-6521-f688-e053-3705fe0a67e0
|
47
|
|
Clinical application of CMR in cardiomyopathies: evolving concepts and techniques. A position paper of myocardial and pericardial diseases and cardiac magnetic resonance working groups of Italian society of cardiology, file 1d1ca322-341f-4e9d-9698-f5d5d9fbadd2
|
46
|
|
Transient versus persistent improved ejection fraction in non-ischaemic dilated cardiomyopathy, file 8891df09-b095-4e7e-ac65-da26d875d357
|
46
|
|
Diagnosis and Management of Rare Cardiomyopathies in Adult and Paediatric Patients. A Position Paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP), file 7fe98c4f-a9de-4442-bdc3-01744d84c51a
|
45
|
|
A big - data classification tree for decision support system in the detection of dilated cardiomyopathy using heart rate variability, file e2913fdd-c744-f688-e053-3705fe0a67e0
|
44
|
|
Using marginal structural joint models to estimate the effect of a time-varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy, file cf2b2367-252a-4710-a5a0-5e5d96bb60e5
|
36
|
|
Prevalence, clinical and instrumental features of left bundle branch block-induced cardiomyopathy: the CLIMB registry, file e2913fdf-667e-f688-e053-3705fe0a67e0
|
36
|
|
Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis, file d5f83f27-534a-4f4e-9d12-db4d83a6dfd5
|
35
|
|
Modifications of medical treatment and outcome after percutaneous correction of secondary mitral regurgitation, file e2913fdd-5106-f688-e053-3705fe0a67e0
|
34
|
|
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator, file 47fefdc4-dfdb-41dd-b894-af07fed403a5
|
33
|
|
Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy, file 52e542cf-32e0-4e29-843a-6c9d3cdd9213
|
33
|
|
The genetic architecture of Plakophilin 2 cardiomyopathy, file 833f5837-d256-4944-81dd-93638261bf72
|
33
|
|
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies, file 1851ed4a-89b8-4429-b25f-013ca26d3d91
|
32
|
|
The genetic architecture of Plakophilin 2 cardiomyopathy, file 62c2c57e-a703-432b-a95a-e85d0a798152
|
32
|
|
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study, file e2913fde-a162-f688-e053-3705fe0a67e0
|
32
|
|
Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy, file 4f6fb757-cf9e-4dbb-84f9-47a0635f7594
|
31
|
|
Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences, file e2913fde-1b0f-f688-e053-3705fe0a67e0
|
28
|
|
Right ventricular dysfunction in right coronary artery infarction: A primary PCI registry analysis, file e2913fdf-223c-f688-e053-3705fe0a67e0
|
28
|
|
Sex differences in natural history of cardiovascular magnetic resonance- and biopsy-proven lymphocytic myocarditis, file a416c6aa-a2a3-4b80-9fae-65869b5aadd7
|
26
|
|
Precision medicine in heart failure no longer a visual theory but a realistic opportunity, file e2913fdf-32cf-f688-e053-3705fe0a67e0
|
26
|
|
Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination, file e2913fdf-a703-f688-e053-3705fe0a67e0
|
26
|
|
Re-Definition of the Epidemiology of Cardiac Amyloidosis, file 02ea8bce-5af2-4278-a776-4e6bf3875b71
|
25
|
|
Clinical presentation and long-term follow-up of perimyocarditis., file e2913fd9-cd20-f688-e053-3705fe0a67e0
|
24
|
|
Cardiac amyloidosis: do not forget to look for it, file e2913fdd-717c-f688-e053-3705fe0a67e0
|
24
|
|
Risk stratification in cardiomyopathy, file e2913fde-29ef-f688-e053-3705fe0a67e0
|
24
|
|
Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications, file 5c8f8a5d-dad9-4ad0-8863-7d4850e66c49
|
23
|
|
The double anaerobic threshold in heart failure: MECKI score database overview, file aab3b79f-eb76-46e1-bb9e-5f046a7adb1f
|
23
|
|
Prognostic significance of unexplained left ventricular hypertrophy in patients undergoing carpal tunnel surgery, file e2913fde-f785-f688-e053-3705fe0a67e0
|
23
|
|
The right ventricular involvement in dilated cardiomyopathy: prevalence and prognostic implications of the often-neglected child, file 2a6ae147-d835-4909-a50c-41f2070a37a0
|
22
|
|
Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF, file 87c4a404-c49c-4367-98ca-7aae829a418e
|
22
|
|
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures, file e2913fdc-9256-f688-e053-3705fe0a67e0
|
21
|
|
Echocardiographic Advances in Dilated Cardiomyopathy, file 544470af-dbe2-48be-8da9-c0e8f06e613a
|
20
|
|
Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience, file d55e096c-fb6e-4733-996b-04a0ec692c39
|
20
|
|
Time to reconsider thromboembolic risk and anticoagulation in transthyretin cardiac amyloidosis?, file eda40954-d911-49ff-a8dc-9bd857cf046f
|
20
|
|
Light-chain cardiac amyloidosis: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy, file f2abbdd0-0b67-49ba-b4f8-c43a5366764b
|
20
|
|
A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation, file 48087595-fc8c-4906-83d7-a06aaa9ba3ac
|
19
|
|
Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis, file e2913fd9-c9de-f688-e053-3705fe0a67e0
|
19
|
|
Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy, file e2913fdf-7f77-f688-e053-3705fe0a67e0
|
19
|
|
Toward a diagnostic CART model for Ischemic heart disease and idiopathic dilated cardiomyopathy based on heart rate total variability, file f521ff55-40a4-48b6-89e5-e5b5078aa63f
|
19
|
|
Cardiovascular Damage in COVID-19: What We Know Two Years Later, file 113a78ba-b012-411f-9f3a-24ea3ece2e1a
|
18
|
|
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review, file c6136752-d193-46da-8290-c62973f3564e
|
18
|
|
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies, file e2913fdd-22f5-f688-e053-3705fe0a67e0
|
18
|
| Totale |
7.930 |